[1]
“A meta-analysis of piperacillin/tazobactam versus cefepime treatment in cancer patients with febrile neutropenia ”, Biosci. J., vol. 32, no. 6, pp. 1669–1678, Dec. 2016, doi: 10.14393/BJ-v32n1a2016-33340.